Rahbar Elaheh, Ainsworth Hannah C, Howard Timothy D, Hawkins Gregory A, Ruczinski Ingo, Mathias Rasika, Seeds Michael C, Sergeant Susan, Hixson James E, Herrington David M, Langefeld Carl D, Chilton Floyd H
Department of Biomedical Engineering, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
PLoS One. 2017 Sep 28;12(9):e0180903. doi: 10.1371/journal.pone.0180903. eCollection 2017.
Genetic variants near and within the fatty acid desaturase (FADS) cluster are associated with polyunsaturated fatty acid (PUFA) biosynthesis, levels of several disease biomarkers and risk of human disease. However, determining the functional mechanisms by which these genetic variants impact PUFA levels remains a challenge. Utilizing an Illumina 450K array, we previously reported strong allele-specific methylation (ASM) associations (p = 2.69×10-29) between a single nucleotide polymorphism (SNP) rs174537 and DNA methylation of CpG sites located in the putative enhancer region between FADS1 and FADS2, in human liver tissue. However, this array only featured 20 CpG sites within this 12kb region. To better understand the methylation landscape within this region, we conducted bisulfite sequencing of the region between FADS1 and FADS2. Liver tissues from 50 male subjects (27 European Americans, 23 African Americans) were obtained from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study, and used to ascertain the genotype at rs174537 and methylation status across the region of interest. Associations between rs174537 genotype and methylation status of 136 CpG sites were determined. Age-adjusted linear regressions were used to assess ASM associations with rs174537 genotype. The majority of CpG sites (117 out of 136, 86%) exhibited high levels of methylation with the greatest variability observed at three key regulatory regions-the promoter regions for FADS1 and FADS2 and a putative enhancer site between the two genes. Eight CpG sites within the putative enhancer region displayed significant (FDR p <0.05) ASM associations with rs174537. These data support the concept that both genetic and epigenetic factors regulate PUFA biosynthesis, and raise fundamental questions as to how genetic variants such as rs174537 impact DNA methylation in distant regulatory regions, and ultimately the capacity of tissues to synthesize PUFAs.
脂肪酸去饱和酶(FADS)基因簇附近及内部的遗传变异与多不饱和脂肪酸(PUFA)生物合成、多种疾病生物标志物水平及人类疾病风险相关。然而,确定这些遗传变异影响PUFA水平的功能机制仍是一项挑战。我们之前利用Illumina 450K芯片,报道了在人类肝脏组织中,单核苷酸多态性(SNP)rs174537与位于FADS1和FADS2之间假定增强子区域的CpG位点的DNA甲基化之间存在强烈的等位基因特异性甲基化(ASM)关联(p = 2.69×10-29)。然而,该芯片在这个12kb区域内仅包含20个CpG位点。为了更好地了解该区域的甲基化格局,我们对FADS1和FADS2之间的区域进行了亚硫酸氢盐测序。从青少年动脉粥样硬化病理生物学决定因素(PDAY)研究中获取了50名男性受试者(27名欧裔美国人,23名非裔美国人)的肝脏组织,用于确定rs174537的基因型以及整个感兴趣区域的甲基化状态。确定了rs174537基因型与136个CpG位点甲基化状态之间的关联。采用年龄校正线性回归评估与rs174537基因型的ASM关联。大多数CpG位点(136个中的117个,86%)表现出高水平的甲基化,在三个关键调控区域——FADS1和FADS-2的启动子区域以及两个基因之间的一个假定增强子位点观察到最大的变异性。假定增强子区域内的8个CpG位点与rs174537表现出显著的(FDR p <0.05)ASM关联。这些数据支持了遗传和表观遗传因素均调节PUFA生物合成的概念,并提出了关于rs174537等遗传变异如何影响远距离调控区域的DNA甲基化以及最终组织合成PUFAs能力的基本问题。